Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
13 hours ago · BOSTON, January 30, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non ...
Vertex’s non-opioid pain drug gets FDA approval in milestone for ...
13 hours ago · Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine
1 day ago · Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective ...
FDA approves new painkiller that shows promise and
13 hours ago · The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ pill, Journavx, for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications like ibuprofen and acetaminophen.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
13 hours ago · The drug, by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat pain from ...
FDA approves first new type of pain medication in 25 years
13 hours ago · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
FDA approves new type of nonopioid painkiller for acute pain
13 hours ago · The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...
Vertex Pharmaceuticals’ non-opioid Journavx approved for pain …
1 day ago · The FDA states: “Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute ...
FDA approves Journavx, new non-opioid painkiller from Vertex: …
13 hours ago · The Food and Drug Administration on Thursday approved a new non-opioid painkiller from Vertex Pharmaceuticals, a pill the drugmaker says poses no risk of addiction and could become an alternative ...
FDA approves new painkiller that shows promise and challenges
13 hours ago · The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' pill, Journavx, for short-term pain that often follows surgery or injuries.
- Some results have been removed